M&A

Novartis Reports the Acquisition of Kate Therapeutics for ~$1.1B

Novartis Reports the Acquisition of Kate Therapeutics for ~$1.1B

Shots Novartis has agreed to acquire Kate Therapeutics, strengthening its portfoli...

BioNTech to Acquire Biotheus, Enhancing its R&D Capabilities in Oncology and Expanding Reach Across China

BioNTech to Acquire Biotheus, Enhancing its R&D Capabilities in Oncology and Expanding Reach Across China

Shots: The acquisition will enhance BioNTech's capabilities in development, ma...

Kalaris Therapeutics Reverse Merges with AlloVir to Advance Therapies Focusing on Retinal Diseases

Kalaris Therapeutics Reverse Merges with AlloVir to Advance Therapies Focusing on Retinal Diseases

Shots: Allovir will acquire 100% outstanding shares of Kalaris, forming a combined...

GHO Capital Partners and Ampersand Capital Partners Report the Acquisition of Avid Bioservices for ~$1.1B

GHO Capital Partners and Ampersand Capital Partners Report the Acquisition of Avid Bioservices for ~$1.1B

Shots: GHO Capital Partners and Ampersand Capital Partners have agreed to acquire...

Boston Scientific Reports the Acquisition of Cortex

Boston Scientific Reports the Acquisition of Cortex

Shots: Boston Scientific has agreed to acquire Cortex (an Ajax Health company), st...

Jade Biosciences Reverse Merges with Aerovate Therapeutics to Advance Standard of Care for Autoimmune Diseases

Jade Biosciences Reverse Merges with Aerovate Therapeutics to Advance Standard of Care for Autoimmune Diseases

Shots: The reverse merger will form a combined entity that will trade as Jade on N...

Image